ArticleAutophagy2023

Targeting NR1H/liver X receptor with dendrogenin A differentiates tumor cells to activate a new secretory pathway releasing immunogenic anti-tumor vesicles enriched in LC3-II-associated exosomes.

Philippe de Medina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.